Overview

Efficacy, Safety, and Tolerability of Oxcarbazepine Monotherapy in Children With Partial Seizures

Status:
Completed
Trial end date:
2007-09-28
Target enrollment:
Participant gender:
Summary
This study is aimed to collect additional data regarding the efficacy in reducing the frequency of partial seizures, as well as the safety and tolerability, of oxcarbazepine monotherapy in children.
Phase:
Phase 4
Details
Lead Sponsor:
Novartis
Treatments:
Carbamazepine
Oxcarbazepine